Michelle Gilson - Arcellx Chief Officer

ACLX Stock  USD 96.86  1.59  1.67%   

Insider

Michelle Gilson is Chief Officer of Arcellx
Age 31
Address 800 Bridge Parkway, Redwood City, CA, United States, 94065
Phone240 327 0603
Webhttps://www.arcellx.com

Latest Insider Transactions

2024-09-17Disposed of 15000 shares @ 77.73View
2024-06-26Disposed of 12877 shares @ 53.7View
2024-05-24Disposed of 12121 shares @ 50.71View

Michelle Gilson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michelle Gilson against Arcellx stock is an integral part of due diligence when investing in Arcellx. Michelle Gilson insider activity provides valuable insight into whether Arcellx is net buyers or sellers over its current business cycle. Note, Arcellx insiders must abide by specific rules, including filing SEC forms every time they buy or sell Arcellx'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Arcellx Management Efficiency

The company has return on total asset (ROA) of (0.0743) % which means that it has lost $0.0743 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.138) %, meaning that it created substantial loss on money invested by shareholders. Arcellx's management efficiency ratios could be used to measure how well Arcellx manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.09 in 2024. Return On Capital Employed is likely to drop to -0.13 in 2024. At this time, Arcellx's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 12.4 M in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (92.1 M).
Arcellx currently holds 97.62 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Arcellx has a current ratio of 9.96, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Arcellx's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Margaret MBAAmylyx Pharmaceuticals
59
Mike PreighDay One Biopharmaceuticals
N/A
Prof MDVentyx Biosciences
N/A
Prof ShairNuvalent
55
PharmD ChiodinDay One Biopharmaceuticals
N/A
Julie MBADay One Biopharmaceuticals
42
Justin KleeAmylyx Pharmaceuticals
33
Stephan MDBiomea Fusion
N/A
Martin MDVentyx Biosciences
49
Heow TanBiomea Fusion
65
Ramses ErdtmannBiomea Fusion
61
John NussVentyx Biosciences
65
MBA JDVentyx Biosciences
56
Naomi CretcherBiomea Fusion
N/A
MD MBAAmylyx Pharmaceuticals
63
James MBAAmylyx Pharmaceuticals
57
Darlene NociNuvalent
46
Thomas ButlerBiomea Fusion
43
Franco ValleBiomea Fusion
43
Christopher MDNuvalent
55
Chris AielloAmylyx Pharmaceuticals
N/A
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland. Arcellx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 78 people. Arcellx (ACLX) is traded on NASDAQ Exchange in USA. It is located in 800 Bridge Parkway, Redwood City, CA, United States, 94065 and employs 130 people. Arcellx is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Arcellx Leadership Team

Elected by the shareholders, the Arcellx's board of directors comprises two types of representatives: Arcellx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arcellx. The board's role is to monitor Arcellx's management team and ensure that shareholders' interests are well served. Arcellx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arcellx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael MBA, Chief Officer
Aileen Fernandes, Chief Officer
Kate Aiken, Chief Officer
Michelle Gilson, Chief Officer
Myesha Lacy, Chief Officer
Christopher MD, Chief Officer
MS JD, General Counsel
Narinderjeet MS, Chief Officer
David Tice, Chief Officer
Neeraj Teotia, Chief Officer
Rami Elghandour, CEO Chairman

Arcellx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arcellx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.